Physician profile
Adarsh K Bhan
NPI 1699783209
$14,638.66
in general payments reported to CMS, 2019-2025
22 companies · $5,053 in 2025
The $5,053 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,095 · 2020: $1,701 · 2021: $465 · 2022: $1,132 · 2023: $2,611 · 2024: $1,582 · 2025: $5,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,889 · Travel and Lodging: $4,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,889.30 |
| Travel and Lodging | $4,356.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,866.54 | 2020-2025 | Farapulse, General - Therapies, Watchman Flx |
| Medtronic Vascular, INC. | $3,189.78 | 2019-2020 | |
| Medtronic, INC. | $2,425.67 | 2021-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Affera Mapping System |
| Stereotaxis INC | $816.28 | 2021-2023 | Niobe |
| Janssen Pharmaceuticals, INC | $453.54 | 2019-2024 | Xarelto |
| Atricure, INC. | $363.43 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Biosense Webster, INC. | $278.96 | 2019-2021 | |
| Abbott Laboratories | $265.85 | 2022-2025 | Aveir, Mitraclip, Ensite |
| Biotronik INC. | $202.15 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $164.31 | 2019-2024 | |
| Esperion Therapeutics, INC. | $121.33 | 2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.34 | 2019-2021 | |
| Cardiva Medical, INC. | $64.36 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Amgen INC. | $57.52 | 2019-2021 | |
| Pfizer INC. | $56.16 | 2019-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $52.41 | 2022-2024 | Assure Wcd |
| Baxter Healthcare | $50.09 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Teleflex LLC | $35.69 | 2024 | Guideliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.70 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $16.31 | 2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $14.24 | 2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adarsh Bhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.